Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Evotec reports loss for 2014

Country: Germany

A large impairment charge for a failed diabetes trial pushed Evotec AG into a loss for 2014 in what was otherwise a year of higher revenue and expanding business opportunities. Impairment charges of €8.5 million gave rise to an operating loss of €6.4 million for the year and a net loss of €7 million.

Read more

SkyePharma outlines investment plans

Country: United Kingdom

SkyePharma will more than double is net investment in research and development this year with plans to advance the clinical development of a new treatment for chronic obstructive pulmonary disease (COPD) as well as new drug delivery technologies.

Read more

EUSA Pharma is reborn

Country: United Kingdom

Read more

Change continues at Zealand Pharma

Country: Denmark

Read more

Outcomes study of Lyxumia completes

Country: France

Read more

Zerhouni calls for regulatory convergence

Country: United Kingdom

Read more

ArGEN-X advances lead antibody

Country: Belgium

Read more

Meeting Report: Focus on cell therapy

Country: France

Read more

Gates makes equity investment in CureVac

Country: United States

Read more

Nicox raises €27 million with share placement

Country: France

Read more

AbbVie to buy Pharmacyclics for $21 billion

Country: United States

Read more

Newron readies first product for market

Country: Italy

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

The story behind Europe's first stem-cell therapy

HoloclarStoryMar15.pdf

Highlights of the March 2015 MedNous issue

The March 2015 MedNous features:

Latest Mednous cover
  • Regenerative Medicine
    The story behind Europe’s first stem-cell therapy
  • Oncology Review
    A window onto oncology drug success rates
    By Bruno Pagliara
  • Business Strategy
    Measuring how drugs bind to their targets
    Interview with Michael Dabrowski
  • Commentary
    The case for drug rediscovery
    by John Lisman
  • Commentary
    Designing new drugs against complex targets
    by Arthur Oubrie

The latest MedNous journal. Subscribe to download.